AMA Delegates Debate: Forming a New Vaccine Advisory Committee or Restoring the ACIP
In a heated debate among AMA delegates, a crucial question arises: Should the American Medical Association (AMA) establish its own vaccine advisory committee or focus on bringing back the disbanded ACIP? This discussion took place during a committee session at the AMA House of Delegates interim meeting, highlighting the ongoing tensions in the medical community regarding vaccine guidance.
The recent actions of HHS Secretary Robert F. Kennedy Jr. have sparked controversy. In June, he removed all 17 members of the Advisory Committee on Immunization Practices (ACIP) and replaced them with vaccine-skeptic allies. This move has led to a fierce debate among medical professionals.
One side advocates for the AMA to form its own vaccine advisory committee, aiming to become a trusted source of science-based vaccine guidance. Dave Cundiff, MD, MPH, a delegate for the American Association of Public Health Physicians (AAPHP), supported this idea, suggesting the AMA convene key stakeholders to develop evidence-based recommendations. However, not all delegates were on board with the proposal, which emphasizes the AMA's role as a 'public-facing megaphone' for vaccine science.
On the other hand, Jason Goldman, MD, president of the American College of Physicians (ACP), warned against adopting the draft resolution due to potential conflicts of interest. The ACP had previously filed a lawsuit against Kennedy's decision to disband the original ACIP, arguing that it undermines vaccine policy and evidence-based medicine. Goldman emphasized the high costs associated with establishing a new body, suggesting that the AMA should instead focus on removing Kennedy's committee and restoring the science-driven ACIP.
The debate also highlighted the need for a coordinated and transparent process in vaccine recommendations. With multiple specialty societies, state governors, and groups offering their own guidance, there is a growing concern about the reliability of vaccine advice. Virginia Dato, MD, a board-certified pediatric and public health physician, emphasized the importance of evidence-based recommendations free from conflicts of interest, citing the loss of experienced ACIP members and dedicated CDC scientific staff.
Despite the challenges, some delegates, like Abhishek Dharan, MD, from the Resident and Fellows Section, believe that the AMA should take a leading role in vaccine recommendation processes. They argue that the AMA has the mechanisms and expertise to convene specialty societies and develop optimal recommendations, rather than relying solely on government decisions.
As the debate continues, the reference committee will present a final report, summarizing the discussions and offering recommendations. The outcome of this debate will significantly impact the future of vaccine guidance in the United States, with potential implications for public health and patient care.
